Hydroxychloroquine does not treat COVID-19, NIH ‘formally’ declares

hydroxychloroquine does not treat covid 19 nih formally declares

Sumary of Hydroxychloroquine does not treat COVID-19, NIH ‘formally’ declares:

  • Hydroxychloroquine does not work, and should not be given to hospitalized coronavirus patients, National Institutes of Health scientists declared in a new study..
  • Regulators revoked that approval in June, however, after reports emerged of heart problems in people who were given the drug, and as studies suggesting the drug was not helping coronavirus patients were published..
  • The NIH stopped its hydroxychloroquine trial on June 19, because of its ‘futility,’ and found hospitalized coronavirus patients given hydroxychloroquine fared no better than those who got a placebo, according to the study published Monday in JAMA..
  • An NIH study has finally formally declared that hydroxychloroquine does not help hospitalized coronavirus patients recover As the U.S..
  • reeled from the whiplash of research suggesting hydroxychloroquine did and didn’t work to treat coronavirus, the NIH was kicking of a large, gold-standard trial..
  • Their study randomly gave half of a group of 479 hospitalized COVID-19 patients hydroxychloroquine and the other half a placebo..
  • Neither the patients nor the health care workers looking after them knew who got the real drug and who got the placebo..
  • Survival rates were actually higher among the coronavirus patients who got a placebo after 14 days (top, blue), but were almost exactly the same among them and the hydroxychloroquine group (orange) after 28 days Discharge rates (white, lightest blue) were slightly higher among patients who got hydroxychloroquine at 14 days (left)(, but were identical by day 28 (right) Fourteen days after admission and treatment, the death rate was actually higher in the hydroxychloroquine group, at 7.4 percent, compared to 5.9 percent of the placebo group..
  • And symptoms while hospitalized were no milder among the people who got the malaria drug, compared to those who didn’t..
  • it was stopped early because the NIH investigators had more than enough evidence that the experimental drug was not helping their patients…

Want to know more click here go to health news source.

From -